This inventor holds 2 USPTO granted patents. Top assignee: Northwestern University. Active years: 2021-2026.
Company Filing History:
Years Active: 2021-2026
Title: Zibo Zhao: Innovator in Cancer Treatment
Introduction
Zibo Zhao is a prominent inventor based in Chicago, IL, known for his significant contributions to cancer research. His innovative work focuses on therapeutic methods for treating cancers characterized by specific genetic alterations.
Latest Patents
Zhao holds a patent titled "Therapeutic targeting of proteolytic cleavage of the mixed lineage leukemia gene product (MLL1) by taspase1 using kinase inhibitors." This patent discloses methods and pharmaceutical compositions aimed at treating cancers, particularly those involving the mixed-lineage leukemia 1 gene product (MLL1). The therapeutic approach involves administering agents that inhibit the cleavage of MLL1 by taspase1, with potential applications in treating Acute Lymphoblastic Leukemia (ALL) and Acute Myeloid Leukemia (AML).
Career Highlights
Zibo Zhao is affiliated with Northwestern University, where he conducts research and develops innovative cancer therapies. His work has garnered attention for its potential to improve treatment outcomes for patients with specific types of leukemia.
Collaborations
Zhao collaborates with Ali Shilatifard, a fellow researcher, to advance their understanding of cancer biology and develop effective therapeutic strategies.
Conclusion
Zibo Zhao's contributions to cancer treatment through his innovative patent highlight the importance of targeted therapies in modern medicine. His work continues to pave the way for advancements in the fight against leukemia and other cancers.